Evidence map›Paper›PMID 24071920›Full record

Trial reportInternational journal of environmental research and public health2013

Can probiotics improve the environmental microbiome and resistome of commercial poultry production?

Adriana A Pedroso, Anne L Hurley-Bacon, Andrea S Zedek, Tiffany W Kwan, Andrea P O Jordan, Gloria Avellaneda, Charles L Hofacre, Brian B Oakley, Stephen R Collett, John J Maurer and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of environmental research and public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Winning the battle of intestinal peace withFrontiers in microbiology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics againstInternational journal of environmental research and public health · 2018
    Article
  13. Article
  14. A Review of Prebiotics AgainstFrontiers in veterinary science · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Blurred Lines: Pathogens, Commensals, and the Healthy Gut.Frontiers in veterinary science · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adriana A PedrosoPoultry Diagnostic and Research Center/Center for Food Safety, The University of Georgia, Athens, GA 30602, USA. mdlee@uga.edu.
Anne L Hurley-Bacon
Andrea S Zedek
Tiffany W Kwan
Andrea P O Jordan
Gloria Avellaneda
Charles L Hofacre
Brian B Oakley
Stephen R Collett
John J Maurer
Margie D Lee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food animal production systems have become more consolidated and integrated, producing large, concentrated animal populations and significant amounts of fecal waste. Increasing use of manure and litter as a more "natural" and affordable source of fertilizer may be contributing to contamination of fruits and vegetables with foodborne pathogens. In addition, human and animal manure have been identified as a significant source of antibiotic resistance genes thereby serving as a disseminator of resistance to soil and waterways. Therefore, identifying methods to remediate human and animal waste is critical in developing strategies to improve food safety and minimize the dissemination of antibiotic resistant bacteria. In this study, we sought to determine whether withdrawing antibiotic growth promoters or using alternatives to antibiotics would reduce the abundance of antibiotic resistance genes or prevalence of pathogens in poultry litter. Terminal restriction fragment length polymorphism (T-RFLP) paired with high throughput sequencing was used to evaluate the bacterial community composition of litter from broiler chickens that were treated with streptogramin growth-promoting antibiotics, probiotics, or prebiotics. The prevalence of resistance genes and pathogens was determined from sequencing results or PCR screens of litter community DNA. Streptogramin antibiotic usage did not elicit statistically significant differences in Shannon diversity indices or correlation coefficients among the flocks. However, T-RFLP revealed that there were inter-farm differences in the litter composition that was independent of antibiotic usage. The litter from all farms, regardless of antibiotic usage, contained streptogramin resistance genes (vatA, vatB, and vatE), macrolide-lincosamide-streptogramin B resistance genes (ermA and ermB), the tetracycline resistance gene tetM and class 1 integrons. There was inter-farm variability in the distribution of vatA and vatE with no statistically significant differences with regards to usage. Bacterial diversity was higher in litter when probiotics or prebiotics were administered to flocks but as the litter aged, diversity decreased. No statistically significant differences were detected in the abundance of class 1 integrons where 3%-5% of the community was estimated to harbor a copy. Abundance of pathogenic Clostridium species increased in aging litter despite the treatment while the abundance of tetracycline-resistant coliforms was unaffected by treatment. However some treatments decreased the prevalence of Salmonella. These findings suggest that withdrawing antibiotics or administering alternatives to antibiotics can change the litter bacterial community and reduce the prevalence of some pathogenic bacteria, but may not immediately impact the prevalence of antibiotic resistance.

Indexed as

ChickensAnimalsAnti-Bacterial AgentsBacteriaBambermycinsDrug Resistance, BacterialEnvironmental MicrobiologyFloors and FloorcoveringsHousing, AnimalProbioticsRNA, Ribosomal, 16SVirginiamycinAnti-Bacterial AgentsBambermycinsRNA, Ribosomal, 16SVirginiamycin

Identifiers

PMID24071920
PMCPMC3823317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.